Osteopontin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameOsteopontin

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionOsteogenesis stimulants

TargetsUpdating

Therapy Area/IndicationsFractures, Bone

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInnogenetics

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesInnogenetics

Active IndicationsN/A

Inactive IndicationsFractures, Bone

ATC CodeN/A